Categories: India

UPDATE 2-US FDA approves Regeneron's drug for generalized myasthenia gravis

(Adds details in paragraphs 5 to 12, analyst's comment in paragraph 9) By Siddhi Mahatole and Kunal Das Nov 18 (Reuters) – The US Food and Drug Administration has approved Regeneron Pharmaceuticals'

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Exclusive-UniCredit and Germany reach broad agreement on Commerzbank takeover

By Holger Hansen BERLIN, Nov 19 (Reuters) - UniCredit and Germany have reached agreement on…

22 seconds ago

UK finance sector cyber incidents hit second-highest level in five years

By Phoebe Seers LONDON, Nov 19 (Reuters) - Cyber incidents reported to Britain's financial watchdog…

1 minute ago

BRIEF-JOYY Reports Third Quarter 2026 Unaudited Financial Results

Nov 18 (Reuters) - Joyy Inc: * JOYY REPORTS THIRD QUARTER 2026 UNAUDITED FINANCIAL RESULTS…

6 minutes ago

China's Jetour to start Brazil car production in 2027, plans $69 million investment

RIO DE JANEIRO, Nov 18 (Reuters) - Chinese automaker Jetour, part of the Chery group,…

11 minutes ago

US Department of Justice charges Russian for targeting Palantir as foreign agent

By Dan Rosenzweig-Ziff WASHINGTON, Nov 18 (Reuters) - A federal grand jury has indicted a…

12 minutes ago

Congressional Daybook/Thursday

REUTERS CONGRESSIONAL DAYBOOK FOR THURSDAY, NOVEMBER 19 ----- The daybook editor is Timothy Ryan (reachable…

17 minutes ago